Steve O'Malley
Steve is a seasoned professional with over 30 years of experience providing strategic guidance to biotech and pharmaceutical clients to help them navigate complex market dynamics. He has successfully led numerous notable product launches by consistently demonstrating the inherent value of innovative therapies. He is also known for his ability to build highly skilled and motivated teams to tackle the challenges of market access and distribution and develop effective solutions to drive success in the ever-evolving field of life sciences.
As President of Petauri Advisors, Steve's priorities are to build a world- class practice of industry veterans to help clients demonstrate the value of their technologies in a dynamic and constantly changing landscape. To accomplish these objectives, Steve will leverage extensive and deep industry relationships. Additionally, he will introduce cross-functional resources, including health economics, medical affairs, and data and analytics, to provide a comprehensive and cohesive range of services to clients.
Steve enjoys working in the start-up environment. Over the past 3 decades, he has successfully established multiple market access teams, from the ground up, within the worlds of pharma and consulting. Steve feels fortunate to have had the opportunity to grow his market access expertise at Amylin Pharmaceuticals and Vertex Pharmaceuticals, becoming the head of market access, successively, at both companies. His tenures at Amylin and Vertex included significant launches within HCV and diabetes, respectively. Steve leveraged the skills gained in those roles to form the Payer Engagement team at PriceSpective, which was acquired by ICON. In 2015, he became President of MKO Global Partners.
Joe Honcz RPh, MBA
Joe is a distinguished expert in managed care and market access, with a robust 25-year career that spans significant sectors of the healthcare industry. Early in his career, Joe played a pivotal role leading teams for the launch of Medicare Part D and, subsequently, contributed to the execution of the Affordable Care Act.
Recognized as a “pharmacy futurist," Joe is highly esteemed for his exceptional ability to anticipate industry trends. His strategic market access insights have enabled over 20 biotech and pharmaceutical clients to effectively maneuver through complex market access and healthcare dynamics. Joe’s contributions have been crucial to the successful launches of innovative products in both traditional and rare/orphan disease categories. As a ”recovering” payer he is uniquely positioned to develop bespoke strategies that solve complicated market challenges, including the successful course correction of brand strategy to optimize access and reimbursement. In his role at Petauri Advisors, Joe plays a key part in shaping market access strategies and supporting the emerging pharmaceutical and health tech industries served by the business unit.
Joe’s extensive background is complemented by diverse roles at Pfizer, Walgreens, and CVS. He holds a BS in pharmacy and an MBA, with a concentration in marketing, from the University of Connecticut, underscoring his deep roots and commitment to the field. He also serves on the Board of Directors for the Academy of Managed Care Pharmacy (AMCP), where he is passionate about mentoring and coaching the next generation of healthcare professionals.
Gina Valerio
Gina Valerio brings extensive experience in market access strategy and marketing across various facets and channels within the healthcare industry. With over 20 years in the field, she has honed her expertise in launching and marketing pharmaceuticals and life sciences technologies to diverse customer segments.
A proven self-starter and critical thinker, Gina has played a pivotal role in the successful launch of several groundbreaking drugs, many of which were first-in-class, including SYMLIN®, BYETTA®, BYDUREON®, OFIRMEV®, and INGREZZA®, as well as numerous oncology molecular diagnostic tests for solid and liquid tumors. Her portfolio encompasses a wide range of therapies, and she has excelled in opening new markets and commercializing several R&D-based companies.
Prior to joining Petauri Advisors, Gina provided strategic market access consultative services to various pharmaceutical and life sciences companies in the San Diego area. She has held positions of increasing responsibility with Amylin Pharmaceuticals, Cadence Pharmaceuticals, Genoptix (a Novartis company), and Santarus Pharmaceuticals.
Gina's extensive knowledge of market access and brand marketing strategy, coupled with her profound understanding of the evolving healthcare landscape, positions her as a highly valued partner for clients navigating today’s market access challenges.
Petauri Advisors. Created in response to overwhelming demand.
Overview of the Petauri Advisors team
Petauri Advisors is a premier global strategic pricing and market access consultancy. Our team comprises industry veterans with extensive training from life science firms, insurers, and consultancies. Leveraging our in-depth understanding of the evolving global payer landscape, we partner with pharmaceutical and biotech clients to craft evidence-based value propositions that support brand launch and life cycle performance to ensure success for our clients.
Capabilities that span the full brand life cycle
Strategy
& Insights
By leveraging the Petauri Payer Research Network, we can proactively gather valuable strategic payer and coverage insights. This approach allows for the generation of archetypes tailored to the evolving payer landscape, facilitating the establishment of customized stakeholder engagement strategies.
Execution & Communication
Utilizing our deep subject-matter expertise in communication and execution across the therapeutic continuum allows for a more tailored approach to address the unique challenges faced by payers, prescribers, and patients/caregivers.
Post-launch Assessment
Assess formulary coverage and access challenges, comprehensively analyzing plans at both national and local levels to identify where action is needed to enhance drug utilization.
The insights you need, wherever and whenever you need them
Petauri Payer Research Network
We leverage our enduring partnerships with payers and pharmaceutical executives to assist you in navigating the intricacies of the US healthcare system. Through our expertise, we identify key influencers and decision-makers crucial to your success, ensuring that you are well positioned to navigate this complex landscape effectively.
We partner with clients to develop powerful messaging customized to payers across global markets
Product
Strategy
- Landscape overview and trends assessment
- Product positioning and gap analysis
-
Patient journey mapping
- Launch sequence optimization, including geography/ indication
- Sales and volume forecasting
Payer
Strategy
- Pricing and reimbursement strategy
- Payer negotiation and value proposition strategy
- Contracting strategy
- Co-pay sensitivity analysis
- Payer segmentation and plan-by-plan assessment
Evidence Generation
and Submission
- Literature review and meta-analysis
- RWE and HEOR strategy execution
- HTA and health economic assessments
- Data aggregation, cleaning, and structuring
- Data analytics
Implementation
Support
- Analysis of payer value drivers and requirement
- Coding strategy, including requirements assessment
- Payer value proposition testing
- Stakeholder mapping
- Distribution channel strategy development and execution
Stakeholder
Communications
- Key stakeholder mapping
- Development of training materials
- Value dossier development
- Payer and advisory board engagement
- Compliance reporting
RWE, real-world evidence; HTA, health technology assessment.
Petauri Advisors Leadership Team
Steve O'Malley
JOE HONCZ, RPh, MBA
